CD274 and colon adenocarcinoma: The current study has shown that the PRlncRNA risk model was strongly related to ICB-related genes (i.e., PD-1, PD-L1), which implied that the PRlncRNA risk model could be utilized to evaluate the response to ICB treatment of COAD patients.